Podcast
Medical Digest & Congress Report
Hosted by Medical Congress News · EN
The MedicalDigest.org / CongressReport.eu podcast covers the latest evidence based medical news from cardiology, hematology, oncology, diabetology, pulmonology, dermatology, urology and more. Made for healthcare professionals and researchers, we are an independent, open-access platform. CongressReport.eu portal enables HCPs to get acquainted with new clinical trial results, medical diagnostic and treatment guidelines. Our non-promotional website collects and stores the relevant scientific information, KOL insights, key lectures, poster presentations in a user-friendly format.
59episodes
Episodes
Newest firstAll episodes
Efficacy and Safety of Enlicitide Decanoate: Results from the Phase 3 CORALreef AddOn Trial - report from ACC 2026
Apr 1000:08:10Tap to summarizeProfessor Alberico L. Catapano presents findings from the Phase 3 CORALreef AddOn trial, evaluating the oral PCSK9 inhibitor enlicitide decanoate versus bempedoic acid and ezetimibe in statin-treated patients with hypercholesterolemia.Video: https://medicaldigest.org/scientific-contents/interview:efficacy-and-safety-enlicitide-decanoate-results-phase-3-coralreef-addon-trial
Transcribe →Highlights of ACC.26
Apr 1000:05:57Tap to summarizeProfessor Christopher Kramer shares the most significant breakthroughs, late-breaking clinical trials, and key takeaways from the ACC 2026 Annual Congress, summarizing the future of cardiovascular care.Video: https://medicaldigest.org/scientific-contents/interview:highlights-acc26
Transcribe →2026 Acute Pulmonary Embolism Guideline
Apr 1000:10:57Tap to summarizeProfessor Mark A. Creager provides an in-depth overview of the newly released 2026 Acute Pulmonary Embolism Guideline, highlighting key updates in clinical management and patient outcomes at the ACC 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:2026-acute-pulmonary-embolism-guideline
Transcribe →Cutting-edge strategies in bladder cancer: Trials, techniques, and predictive tools - report from EAU 2026
Apr 700:09:53Tap to summarizeProfessor Richard P. Meijer explores the frontier of bladder cancer management, focusing on innovative clinical trials, advanced surgical techniques, and the implementation of predictive tools to improve patient outcomes at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:cutting-edge-strategies-bladder-cancer
Transcribe →MIBC - There is a gender bias in bladder cancer diagnosis and treatment - Women experience delays, misdiagnosis, worse outcomes - report from EAU 2026
Apr 700:05:30Tap to summarizeProfessor Niyati Lobo addresses the critical issue of gender bias in bladder cancer, highlighting how diagnostic delays and misdiagnoses lead to significantly worse clinical outcomes for women with MIBC at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:mibc-there-gender-bias-bladder-cancer-diagnosis-and-treatment-women-experience-delays-misdiagnosis-worse-outcomes
Transcribe →Guidelines Controversies - Paeds and MIBC - report from EAU 2026
Apr 700:08:10Tap to summarizeProfessor Antoine G. van der Heijden explores the most debated topics within the EAU Guidelines, focusing on the latest controversies in pediatric urology and the management of Muscle-Invasive Bladder Cancer (MIBC) at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:guidelines-controversies-paeds-and-mibc
Transcribe →Adaptive recurrence risk predictions to optimise prostate cancer follow-up: Results of model validation and clinical impact - report from EAU 2026
Apr 700:04:28Tap to summarizeJoran Schoorlemmer presents the results of model validation and the clinical impact of adaptive recurrence risk predictions, focusing on how these tools can optimise follow-up strategies for prostate cancer at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:adaptive-recurrence-risk-predictions-optimise-prostate-cancer-follow-results-model-validation-and-clinical-impact
Transcribe →The role of urine biomarkers in detection of bladder cancer - report from EAU 2026
Apr 700:06:36Tap to summarizeProfessor Yair Lotan examines the clinical utility and future potential of urine biomarkers, focusing on how they are transforming the early detection and surveillance of bladder cancer at the EAU 2026 Annual Congress.Video: https://medicaldigest.org/scientific-contents/interview:role-urine-biomarkers-detection-bladder-cancer
Transcribe →Increasing role of triple therapy in COPD - report from IWLH 2026
Jan 3000:11:21Tap to summarizeProfessor Fabiano Di Marco ediscusses the increasing role of triple therapy in COPD at the 13th International Workshop On Lung Health.Video: https://medicaldigest.org/scientific-contents/interview:increasing-role-triple-therapy-copd
Transcribe →Redefining epithelial driven airway inflammation: insights from clinical experience with Tezepelumab - report from IWLH 2026
Jan 3000:03:54Tap to summarizeProfessor Corrado Pelaia explains his insights from clinical experience with Tezepelumab at the 13th International Workshop On Lung Health.Video: https://medicaldigest.org/scientific-contents/interview:redefining-epithelial-driven-airway-inflammation-insights-clinical-experience-tezepelumab
Transcribe →